Cargando…
Potential Role of Rebamipide in Osteoclast Differentiation and Mandibular Condylar Cartilage Homeostasis
BACKGROUND: Temporomandibular joint osteoarthritis (TMJ-OA) is a degenerative disease that involves changes in subchondral bone and progressive degradation of cartilage. Currently, rebamipide, a gastroprotective drug, is administered to protect gastric mucosa and accelerate ulcer healing. OBJECTIVES...
Autores principales: | Izawa, Takashi, Hutami, Islamy Rahma, Tanaka, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925868/ https://www.ncbi.nlm.nih.gov/pubmed/29046162 http://dx.doi.org/10.2174/1573397113666171017113441 |
Ejemplares similares
-
Rebamipide Attenuates Mandibular Condylar Degeneration in a Murine Model of TMJ-OA by Mediating a Chondroprotective Effect and by Downregulating RANKL-Mediated Osteoclastogenesis
por: Izawa, Takashi, et al.
Publicado: (2016) -
Correction: Rebamipide Attenuates Mandibular Condylar Degeneration in a Murine Model of TMJ-OA by Mediating a Chondroprotective Effect and by Downregulating RANKL-Mediated Osteoclastogenesis
por: Izawa, Takashi, et al.
Publicado: (2016) -
Crosstalk between Fas and S1P(1) signaling via NF-kB in osteoclasts controls bone destruction in the TMJ due to rheumatoid arthritis
por: Hutami, Islamy Rahma, et al.
Publicado: (2019) -
Macrophage Motility in Wound Healing Is Regulated by HIF-1α via S1P Signaling
por: Hutami, Islamy Rahma, et al.
Publicado: (2021) -
The Effect of Altered Loading on Mandibular Condylar Cartilage
por: Kaul, Raman, et al.
Publicado: (2016)